Dec 10, 2018, 11:25 AM by Michael Croft

Bio-IT World Brief   10x Genomics has acquired Stockholm-based Spatial Transcriptomics, a pioneer in the emerging field of spatial genomics. The new field enables researchers to not only see what is in a cell but how cells are organized in relation to one another, offering up invaluable insight into understanding disease.

Dec 10, 2018, 11:12 AM by Michael Croft

GUILDFORD, UNITED KINGDOM - Dec 10, 2018 - The partnership announced today between Qlucore and Cambridge Protein Arrays Ltd (CPA) will strengthen the end-to-end solution for protein analysis

Dec 10, 2018, 09:13 AM by Michael Croft

CAMBRIDGE, MA, UNITED STATES - Dec 10, 2018 - HiFiBiO Therapeutics, a world leader in the discovery of therapeutic antibodies through single-cell screening and analysis, today announced the formation of Victa Biotherapeutics, a joint venture with Vikas P

Dec 10, 2018, 08:50 AM by Michael Croft

PLEASANTON, CA, UNITED STATES - Dec 10, 2018 - 10x Genomics today announced the acquisition of Stockholm-based Spatial Transcriptomics, a pioneer in the emerging field of spatial genomics

Dec 7, 2018, 12:04 PM by Michael Croft

CHAPEL HILL, NC - Dec 7, 2018 -  Rho Experts Explore Right-to-Try Legislation and ExistingExpanded Access Programs in Free Webinar WHAT:                 The impact of Right-to-Try legislation has been in the news a lot recently, but what does the legislation mean for product sponsors? Rho, a full-service contract research organization (CRO), will explore both Right-to-Try legislation and existing Expanded Access Programs in a new free webinar, including:o   Understanding sponsor responsibilities under these programs and when products may be eligibleo   Evaluating options such as treatment protocols, treatment INDs, and emergency useo   Discussing development risks associated with participation in these programs The webinar, "Right-to-Try or Right-to-Ask? Understanding Right-to-Try and FDA's Expanded Access," will take place on Tuesday, Dec

Dec 6, 2018, 11:45 AM by Michael Croft

Dec 6, 2018, 09:03 AM by Michael Croft

PLYMOUTH MEETING, PA - Dec 6, 2018 - Clinical research and technology leaders from across the industry will share their data and expertise at an upcoming webinar hosted by CRF Health, a CRF Bracket company, to discuss how to improve patient centricity through electronic informed consent (eConsent)

Dec 5, 2018, 14:45 PM by Michael Croft

RANCHO SANTA MARGARITA, CA, UNITED STATES - Dec 4, 2018 - Melissa Unlocks Insight and Revenue with Breakthrough AI Tools for Clinics and Research CentersCutting Edge Data Quality Transforms Real-World Clinical Data into aFuture-Proofed, Research-Ready Data Goldmine for Better Patient CareMelissa, a leading provider of global contact data quality and identity verification solutions, today announced advanced artificial intelligence (AI) solutions that combine machine reasoning, natural language processing, and machine learning to tackle one of healthcare's biggest problems: the time and cost of data harmonization and integration

Dec 5, 2018, 13:47 PM by Michael Croft

EDINA, MN - Dec 5, 2018 - Equus Compute Solutions announces the release of its new G2660 2U 2xGPU server, ideal for artificial intelligence and deep learning environments

Dec 5, 2018, 11:11 AM by Michael Croft

KANSAS CITY, KS, UNITED STATES - Dec 5, 2018 - Sekisui XenoTech has created a Scientific Advisory Board (SAB) of renowned scientists and thought leaders in the pharmaceutical industry

Dec 5, 2018, 10:39 AM by Michael Croft

Endpoints News | GlaxoSmithKline has struck a deal to buy Tesaro in a $5.1 billion deal that will vault the pharma giant into the commercial oncology market as it stakes out a big new role for itself in the booming cancer field.

Dec 5, 2018, 09:20 AM by Michael Croft

Dec 5, 2018, 08:14 AM by Michael Croft

PRINCETON, NJ - Dec 5, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced the launch of its BaseCase Toolkits, an add-on to BaseCase Interactive which helps pharmaceutical and medical device field representatives better manage and utilize their resources for use during customer presentations

Dec 5, 2018, 05:48 AM by Michael Croft

EDINBURGH, UK - Dec 5, 2018 - Synpromics is pleased to hear that its partner, uniQure (NASDAQ:QURE), has announced the incorporation of its promoter, developed by Synpromics, in a new preclinical research target

Dec 4, 2018, 01:02 AM by Michael Croft

LONG ISLAND CITY, NY, UNITED STATES - Dec 4, 2018 - Starting from the year of 2013, BOC Sciences has been providing a wide variety of metabolites and impurities for scientists in the research community

Dec 4, 2018, 00:58 AM by Michael Croft

LONG ISLAND CITY, NY, UNITED STATES - Dec 4, 2018 - Earlier this October, Creative Peptides, one of the world’s leading peptide manufacturers, has announced a series of peptide modification services

Dec 3, 2018, 11:27 AM by Michael Croft

CHAPEL HILL, NC, UNITED STATES - Dec 3, 2018 - TARGET PharmaSolutions, Inc., a company focused on real-world evidence, is pleased to announce that Bristol Myers Squibb has entered into a strategic partnership for TARGET-IBD

Nov 30, 2018, 11:22 AM by Michael Croft

MIT Technology Review | Even as a furious debate broke out in China over gene-edited babies, some scientists in the US are also hoping to improve tomorrow's children.

Nov 30, 2018, 11:17 AM by Michael Croft

BAR HARBOR, ME, UNITED STATES - Nov 30, 2018 - Vicki P. Losick, Ph.D., has been named the inaugural recipient of an award from the William Procter Scientific Innovation Fund

Nov 30, 2018, 09:45 AM by Michael Croft

KING OF PRUSSIA, PA, UNITED STATES - Nov 27, 2018 - Greenphire, the global leader in financial technology for clinical trials, announced today that it has been ranked as 391 on Deloitte's 2018 Technology Fast 500™